Combining experimental information from crystal and solution studies: joint X-ray and NMR refinement.

Joint refinement of macromolecules against crystallographic and nuclear magnetic resonance (NMR) observations is presented as a way of combining experimental information from the two methods. The model of interleukin-1 beta derived by the joint x-ray and NMR refinement is shown to be consistent with the experimental observations of both methods and to have crystallographic R value and geometrical parameters that are of the same quality as or better than those of models obtained by conventional crystallographic studies. The few NMR observations that are violated by the model serve as an indicator for genuine differences between the crystal and solution structures. The joint x-ray-NMR refinement can resolve structural ambiguities encountered in studies of multidomain proteins, in which low- to medium-resolution diffraction data can be complemented by higher resolution NMR data obtained for the individual domains.

[1]  Wayne A. Hendrickson,et al.  A procedure for joint refinement of macromolecular structures with X‐ray and neutron diffraction data from single crystals , 1982 .

[2]  M. Grütter,et al.  Crystallographic refinement of interleukin 1 beta at 2.0 A resolution. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Gronenborn,et al.  Crystal structure of interleukin 8: symbiosis of NMR and crystallography. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Huber,et al.  Solution of the phase problem in the X-ray diffraction method for proteins with the nuclear magnetic resonance solution structure as initial model. Patterson search and refinement for the alpha-amylase inhibitor tendamistat. , 1989, Journal of molecular biology.

[5]  K. Wüthrich Protein structure determination in solution by nuclear magnetic resonance spectroscopy. , 1989, Science.

[6]  Barry C. Finzel,et al.  Crystal structure of recombinant human interleukin-1β at 2·0 Å resolution , 1989 .

[7]  A M Gronenborn,et al.  Structures of larger proteins in solution: three- and four-dimensional heteronuclear NMR spectroscopy. , 1991, Science.

[8]  A. Brunger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[9]  C. Chothia The nature of the accessible and buried surfaces in proteins. , 1976, Journal of molecular biology.

[10]  A. Gronenborn,et al.  Comparison of the solution nuclear magnetic resonance and crystal structures of interleukin-8. Possible implications for the mechanism of receptor binding. , 1991, Journal of molecular biology.

[11]  M. Karplus,et al.  Solution of a Protein Crystal Structure with a Model Obtained from NMR Interproton Distance Restraints , 1987, Science.

[12]  A. Gronenborn,et al.  Determination of three‐dimensional structures of proteins from interproton distance data by hybrid distance geometry‐dynamical simulated annealing calculations , 1988, FEBS letters.

[13]  M. Karplus,et al.  Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.

[14]  M Karplus,et al.  Solution conformations of human growth hormone releasing factor: comparison of the restrained molecular dynamics and distance geometry methods for a system without long-range distance data. , 1987, Protein engineering.

[15]  R. Huber,et al.  Nuclear magnetic resonance solution and X-ray structures of squash trypsin inhibitor exhibit the same conformation of the proteinase binding loop. , 1989, Journal of molecular biology.

[16]  A. Gronenborn,et al.  Comparison of the solution nuclear magnetic resonance and X-ray crystal structures of human recombinant interleukin-1 beta. , 1991, Journal of molecular biology.

[17]  Talapady N. Bhat,et al.  OMITMAP: An electron density map suitable for the examination of errors in a macromolecular model , 1984 .

[18]  Michael Levitt,et al.  Refinement of Large Structures by Simultaneous Minimization of Energy and R Factor , 1978 .

[19]  M Karplus,et al.  Three-dimensional structure of proteins determined by molecular dynamics with interproton distance restraints: application to crambin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K Wüthrich,et al.  Comparison of the high-resolution structures of the alpha-amylase inhibitor tendamistat determined by nuclear magnetic resonance in solution and by X-ray diffraction in single crystals. , 1989, Journal of molecular biology.